Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03774849 · ClinicalTrials.gov registry record · NA
PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles
A NA study of Facial Wrinkles and Benign Pigmented Lesions, sponsored by Candela Corporation.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
- 1
- Study location
NCT03774849 is a NA study of Facial Wrinkles and Benign Pigmented Lesions that has completed, run by Candela Corporation. The registered enrollment target is 115 participants, above the 68-participant average among 6 other Facial Wrinkles trials with a reported enrollment target (69% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03774849, a NA study of Facial Wrinkles and Benign Pigmented Lesions, has completed, sponsored by Candela Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluation of the PicoWay™ Laser System With 730nm and Resolve™ Fusion Handpieces for Treatment of Benign Pigmented Lesions and Wrinkles.
Conditions Studied
Interventions
- DEVICE PicoWay™ 532nm fractional handpiece
- DEVICE PicoWay™ 730nm wavelength
- DEVICE PicoWay™ 1064nm fractional handpiece
Study Locations (1)
Massachusetts
- Syneron Candela Institute for Excellence - Wayland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2020-11-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03774849
The ClinicalTrials.gov registry entry for NCT03774849 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 68-participant average among 6 other Facial Wrinkles trials with a reported enrollment target (69% higher). The listed sponsor is Candela Corporation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Facial Wrinkles appearing as the primary indexed condition, and to 3 interventions - of which PicoWay™ 532nm fractional handpiece is the first listed.
NCT03774849 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03774849 about?
NCT03774849 is a clinical study titled "PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles". Evaluation of the PicoWay™ Laser System With 730nm and Resolve™ Fusion Handpieces for Treatment of Benign Pigmented Lesions and Wrinkles.
What is the current status of trial NCT03774849?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2018-12-05. Estimated completion is 2020-11-12.
What conditions does trial NCT03774849 study?
This clinical trial studies the following conditions: Facial Wrinkles, Benign Pigmented Lesions.
What interventions are being tested in trial NCT03774849?
The interventions under investigation include: PicoWay™ 532nm fractional handpiece (DEVICE), PicoWay™ 730nm wavelength (DEVICE), PicoWay™ 1064nm fractional handpiece (DEVICE).
Who is sponsoring clinical trial NCT03774849?
This trial is sponsored by Candela Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03774849 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facial Wrinkles
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles
COMPLETED · NA
-
Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
COMPLETED · Phase 2
-
Cryo-Touch II for the Treatment of Wrinkles
COMPLETED · Phase 2
-
A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)
COMPLETED · Phase 3
-
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
COMPLETED · Phase 2
-
A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.